Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Down's syndrome (DS) or trisomy 21 is the most common genetic cause of mental retardation. Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. The cause of the neurodegenerative process in DS is unknown. Here we report that cortical neurons from fetal DS and age-matched normal brain differentiate normally in culture, but DS neurons subsequently degenerate and undergo apoptosis whereas normal neurons remain viable. Degeneration of DS neurons is prevented by treatment with free-radical scavengers or catalase. Furthermore, DS neurons exhibit a three- to fourfold increase in intracellular reactive oxygen species and elevated levels of lipid peroxidation that precede neuronal death. These results suggest that DS neurons have a defect in the metabolism of reactive oxygen species that causes neuronal apoptosis. This defect may contribute to mental retardation early in life and predispose to Alzheimer's disease in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other biomarkers of increased oxidative damage in the brains of persons with DS and persons with DS with AD neuropathology (DS with AD) include elevated levels of HNE and PC15,42; the increases are greater in people with DS with AD62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“Analysis of such cortical neurons from fetuses, confirmed significantly increased levels of ROS responsible for apoptosis (Busciglio and Yanker 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Busciglio and Yanker 1995
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,809
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
Cathcart, R., Schwiers, E., & Ames, B. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90270-1 · Cited by 852
Greenlund, L. J. S., Deckwerth, T. L., & Johnson, E. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90287-2 · Cited by 742
Programmed cell death and Bcl-2 protection in very low oxygen
Jacobson, M. D., & Raff, M. C. (1995) · Nature · doi:10.1038/374814a0 · Cited by 625
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Research works printed but not linked: 1
- Becker, L., Mito, T., Takashima, S. & Onodera, K. Prog. clin. biol. Res. 373, 133–152 (1991).
Cited by
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944
“Alterations induced by xenobiotics can result in the progressive loss of neurons and may result in compromised neurological function later in life, as is the case in some neurodegenerative diseases (124-128).”
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
“Interesting, empty exosomes also decreased ROS levels in activated macrophages down to the levels of the control non-activated cells, although this effect was less significant than the effect of exoCAT.”
BackgroundInfluentialOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
“In vitro cultured DS neurons derived from fetal DS also demonstrated higher levels of ROS and signi fi cant oxidative damage [63].”
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Self-citationRisks of leukaemia and solid tumours in individuals with Down's syndrome
Hasle, H., Clemmensen, I. H., & Mikkelsen, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05264-2 · Cited by 892
Initiation of Runaway Cell Death in an Arabidopsis Mutant by Extracellular Superoxide
Jabs, T., Dietrich, R. A., & Dangl, J. L. (1996) · Science · doi:10.1126/science.273.5283.1853 · Cited by 874
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
REST and stress resistance in ageing and Alzheimer’s disease
Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T.-H., Kim, H.-M., Drake, D., Liu, X. S., et al. (2014) · Nature · doi:10.1038/nature13163 · Cited by 772
Self-citationXu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
“Characterization of cultured human dopaminergic neurons To investigate the role of α-synuclein in the selective degeneration of dopaminergic neurons in PD, we established a model of α-synuclein accumulation in cultures of human fetal dopaminergic neurons (DAN cells) and non-dopaminergic human cortical neurons (HCN cel…”
BackgroundSelf-citationBains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 717
Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence
Niki, E. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.022 · Cited by 670
ROS and diseases: role in metabolism and energy supply
Yang, S., & Lian, G. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03667-9 · Cited by 658
Do children really recover better? Neurobehavioural plasticity after early brain insult
Anderson, V., Spencer-Smith, M., & Wood, A. (2011) · Brain · doi:10.1093/brain/awr103 · Cited by 584
“While necessary for healthy development, excessive rates of apoptosis have been linked to conditions such as Down syndrome (Busciglio and Yanker, 1995).”
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Reactive oxygen intermediates as mediators of programmed cell death in plants and animals
Jabs, T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00227-5 · Cited by 596
Reactive oxygen species are downstream mediators of p53-dependent apoptosis.
Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A., & Finkel, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11848 · Cited by 596
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562
BILLINGSLEY, M. L., & KINCAID, R. L. (1997) · Biochemical Journal · doi:10.1042/bj3230577 · Cited by 453
de Haan, J. B., Bladier, C., Griffiths, P., Kelner, M., O'Shea, R. D., Cheung, N. S., Bronson, R. T., Silvestro, M. J., Wild, S., Zheng, S. S., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22528 · Cited by 450
Thorpe, G. W., Fong, C. S., Alic, N., Higgins, V. J., & Dawes, I. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305888101 · Cited by 450
Antioxidants and oxidants regulated signal transduction pathways
Owuor, E. D., & Kong, A.-N. T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01137-1 · Cited by 439
Stadelmann, C., Deckwerth, T. L., Srinivasan, A., Bancher, C., Brück, W., Jellinger, K., & Lassmann, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 428
Mitochondria, free radicals, and neurodegeneration
Beal, M. F. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80100-0 · Cited by 424
N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
Bavarsad Shahripour, R., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 410
“Cysteine is transported mainly by the alanine-serine-cysteine (ASC) system, a ubiquitous system of Na+-dependent neutral amino acid transport in a variety of cells (Bannai and Tateishi 1986; Ishige et al. 2005).”
BackgroundElevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease
Lovell, M. A., Ehmann, W. D., Mattson, M. P., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00108-5 · Cited by 412
Antioxidant Therapies for Alzheimer's Disease
Feng, Y., & Wang, X. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/472932 · Cited by 379
Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
Self-citationOxidative injury in diseases of the central nervous system: focus on alzheimer’s disease
Praticò, D., & Delanty, N. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00547-7 · Cited by 378
Mao, W., Yu, X. X., Zhong, A., Li, W., Brush, J., Sherwood, S. W., Adams, S. H., & Pan, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01713-x · Cited by 377
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Single‐Atom Catalysts in Catalytic Biomedicine
Xiang, H., Feng, W., & Chen, Y. (2020) · Advanced Materials · doi:10.1002/adma.201905994 · Cited by 368
Zhang, P., Liu, B., Kang, S. W., Seo, M. S., Rhee, S. G., & Obeid, L. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30615 · Cited by 371
The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease
Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369
Reactive oxygen species and the mitochondrial signaling pathway of cell death.
Bras, M. L., Clément, M.-V., Pervaiz, S., & Brenner, C. (2005) · PubMed · doi:10.14670/hh-20.205 · Cited by 359
Mitochondria in Neurodegeneration: Acute Ischemia and Chronic Neurodegenerative Diseases
Fiskum, G., Murphy, A. N., & Beal, M. F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00001 · Cited by 350
Ge, C., Fang, G., Shen, X., Chong, Y., Wamer, W. G., Gao, X., Chai, Z., Chen, C., & Yin, J.-J. (2016) · ACS Nano · doi:10.1021/acsnano.6b06297 · Cited by 343
Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O'Dell, T. J., Fung, J., Weier, H.-U. G., Cheng, J.-F., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-28 · Cited by 321
Neuronal Oxidative Stress Precedes Amyloid-β Deposition in Down Syndrome
Nunomura, A., Perry, G., Pappolla, M. A., Friedland, R. P., Hirai, K., Chiba, S., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.1011 · Cited by 320
Johnstone, M., Gearing, A. J. H., & Miller, K. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 313
Perluigi, M., Di Domenico, F., & Butterfield, D. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 282
Antioxidant activities of Salvia miltiorrhiza and Panax notoginseng
ZHAO, G., XIANG, Z., YE, T., YUAN, Y., & GUO, Z. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2005.09.002 · Cited by 312
A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome
Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S. H., & Livesey, F. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003771 · Cited by 310
“Why this aspect of the disease process is accelerated in culture is a focus of ongoing work butmay be due to the increased production of reactive oxygen species byDown syndrome neurons in culture (34).”
Münch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G., & Riederer, P. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050069 · Cited by 304
“Moreover, neurons in culture from Down’s syndrome cases undergo a premature apoptotic death that is delayed by antioxidants (Busciglio and Yankner, 1995).”
BackgroundChromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress
Higuchi, Y. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00508-2 · Cited by 302
Mancini, M., Anderson, B. O., Caldwell, E., Sedghinasab, M., Paty, P. B., & Hockenbery, D. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.2.449 · Cited by 305
“Similar ROS-mediated mitochondrial membrane damage has been detected as a possible cause of apoptosis in Down’s syndrome human fetal cortical neurons (11).”
BackgroundAlzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport
Pigino, G., Morfini, G., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 302
“Neuronal viability was assessed by a propidium iodide exclusion assay as previously described (Busciglio and Yankner, 1995; Grace et al., 2002; Grace and Busciglio, 2003).”
MethodSelf-citationCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
“1996), exhibit lipid peroxidation and apoptotic cell death caused by increased generation of H2O2 (Busciglio and Yankner, 1995).”
BackgroundAlzheimer's disease in Down syndrome: Neurobiology and risk
Zigman, W. B., & Lott, I. T. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20163 · Cited by 278
Pattern of malignant disorders in individuals with Down's syndrome
Hasle, H. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00435-6 · Cited by 286
Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense
da-Silva, W. S., Gómez-Puyou, A., de Gómez-Puyou, M. T., Moreno-Sanchez, R., De Felice, F. G., de Meis, L., Oliveira, M. F., & Galina, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403835200 · Cited by 281
Cyclooxygenases and the Central Nervous System
Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., & Worley, P. F. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00128-7 · Cited by 285
Oxidative Stress Inhibits Apoptosis in Human Lymphoma Cells
Lee, Y.-J., & Shacter, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19792 · Cited by 275
The role of lipid peroxidation in neurological disorders
Shichiri, M. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-10 · Cited by 269
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
Li, F., Calingasan, N. Y., Yu, F., Mauck, W. M., Toidze, M., Almeida, C. G., Takahashi, R. H., Carlson, G. A., Flint Beal, M., Lin, M. T., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02455.x · Cited by 276
Beal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Human catalase: looking for complete identity
Goyal, M. M., & Basak, A. (2010) · Protein & Cell · doi:10.1007/s13238-010-0113-z · Cited by 273
“Catalase was shown to be effective in inhibiting the degeneration of neurons (Busciglio and Yankner, 1995; Mann et al., 1997).”
BackgroundKong, A.-N. T., Yu, R., Chen, C., Mandlekar, S., & Primiano, T. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976458 · Cited by 274
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
Ye, Z., Zhuo, Q., Hu, Q., Xu, X., liu, M., Zhang, Z., Xu, W., Liu, W., Fan, G., Qin, Y., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101807 · Cited by 267
“Both reduced GSH/GSSG ratio and increased lipid peroxidation could induce ferroptosis and apoptosis [32, 33].”
BackgroundKitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M. A., Perry, G., Whitehouse, P. J., & Taniguchi, T. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01202-x · Cited by 269
Lee, J. H., Khor, T. O., Shu, L., Su, Z.-Y., Fuentes, F., & Kong, A.-N. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.008 · Cited by 247
“Several MAP3Ks, including members of the MEKK family ASK1, MLK, TAK1 and TPL-2, have been reported to act as MAP3Ks in JNK activation (Busciglio & Yankner, 1995; Nakahara et al., 1999; Raman et al., 2007).”
BackgroundApoptosis in Human Disease: A New Skin for the Old Ceremony?
Fadeel, B., Orrenius, S., & Zhivotovsky, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1888 · Cited by 249
Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249
“Previous research has demonstrated mitochondrial site specificity for CCCP (Thayer and Miller, 1990; Friel and Tsien, 1994; Buttgereit and Brand, 1995; Park et al., 1996).”
BackgroundThe Role of Cell Death in Regulating the Size and Shape of the Mammalian Forebrain
Haydar, T. F. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.6.621 · Cited by 237
“For example, abnormally high rates of apoptosis occur in Down syndrome both during and after forebrain neurogenesis (Wisniewski and Kida, 1994; Busciglio and Yankner, 1995).”
Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241
“Oxidative stress is a possible contributory factor in DS and AD pathogenesis, and decreased viability of fetal DS neurons in culture has been linked to increased reactive oxygen species (Busciglio and Yankner, 1995).”
Logjam at the Styx: programmed cell death in plants
Jones, A. M., & Dangl, J. L. (1996) · Trends in Plant Science · doi:10.1016/s1360-1385(96)90005-9 · Cited by 239
Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
“Accordingly, Busciglio and Yankner (31) demonstrated increased production of ROS and elevated levels of lipid peroxidation in neurons of DS fetuses.”
Reactive oxygen species and Alzheimer's disease
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., & Beyreuther, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00062-2 · Cited by 227
Oxidative stress potentiates BACE1 gene expression and A? generation
Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0255-3 · Cited by 218
“Down syndrome neurons show increase in intracellular reactive oxygen species and the defect in the metabolism of reactive oxygen species might cause neuronal apoptosis (Busciglio and Yankner, 1995).”
BackgroundChen, C., Jiang, P., Xue, H., Peterson, S. E., Tran, H. T., McCann, A. E., Parast, M. M., Li, S., Pleasure, D. E., Laurent, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5430 · Cited by 219
“Coincidently, the otherwise seemingly normal DS neurons show abnormal morphology in the presence of DS astroglia; (3) adding control ACM restores the defects of DS neurons grown in the presence DS astroglia, such as shorter neurite length and increased apoptosis; (4) unlike control ACM, DS ACM fails to promote the mat…”
BackgroundLizard, G., Gueldry, S., Sordet, O., Monier, S., Athias, A., Miguet, C., Bessede, G., Lemaire, S., Solary, E., & Gambert, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1651 · Cited by 215
“Indeed, ROS production has soon been revealed during spontaneous apoptosis described throughout the degeneration of cultured Down’s syndrome neurons (23), as well as in apoptosis induced by biological, chemical, or physical agents (21, 67).”
BackgroundMNB/DYRK1A as a multiple regulator of neuronal development
Tejedor, F. J., & Hämmerle, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07954.x · Cited by 214
“For instance, cultured human cortical DS neurons exhibit intracellular oxidative stress and increased apoptosis (Busciglio and Yankner, 1995).”
BackgroundReiter, R. J., Tan, D.-X., & Burkhardt, S. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00384-0 · Cited by 213
N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology
Arakawa, M., & Ito, Y. (2007) · The Cerebellum · doi:10.1080/14734220601142878 · Cited by 206
“DS, a classic mental deficiency disease resulting from trisomy of chromosome 21, is known to involve increased systemic oxidative stress (62).”
BackgroundA Macrophage−Nanozyme Delivery System for Parkinson's Disease
Batrakova, E. V., Li, S., Reynolds, A. D., Mosley, R. L., Bronich, T. K., Kabanov, A. V., & Gendelman, H. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700184b · Cited by 209
Clément, M.-V., Ponton, A., & Pervaiz, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01410-0 · Cited by 205
Deficits in human trisomy 21 iPSCs and neurons
Weick, J. P., Held, D. L., Bonadurer, G. F., Doers, M. E., Liu, Y., Maguire, C., Clark, A., Knackert, J. A., Molinarolo, K., Musser, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216575110 · Cited by 205
“However, we did not see a significant increase in cell death in DS iPSCs or neurons, suggesting that OS gene up-regulation may act as a compensatory mechanism to allow survival of Ts21 cells, consistent with previous studies using exogenous catalase (47).”
BackgroundResultInfluentialMolecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
“Programmed cell death could be rescued by administration of free radical scavengers including vitamin E, and N-tert-butyl-2sulphophenylnitrone [263] but dietary parameters did not alleviate oxidative stress biomarkers in young adult DS patients [20].”
BackgroundValenti, D., de Bari, L., De Filippis, B., Henrion-Caude, A., & Vacca, R. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.012 · Cited by 189
Pathophysiology of perinatal brain damage
Berger, R., & Garnier, Y. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00009-0 · Cited by 203
Guo, Q., Sebastian, L., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721019.x · Cited by 197
(2001) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(01)35014-x · Cited by 194
Chen, Q., Galleano, M., & Cederbaum, A. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14532 · Cited by 199
Human Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
“These results validate reports that neurons and progenitor cells derived fromDS post-mortem fetal tissue have increased susceptibility to oxidative stress.(286,342,343) Recent bioinformatics analyses of human and mouse DS fetal-brain transcriptomes have indicated that specific common pathway abnormalities leading to o…”
ResultOxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
“Consonant with the above-cited studies, Busciglio and Yankner [14] reported that neurons of DS patients exhibited a sharp increase in intracellular ROS which is also accompanied by elevated levels of lipid peroxidation.”
BackgroundResultInfluentialMacrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
“The neuropathology associated with PD involves brain inflammation, microglial activation, subsequent secretion of neurotoxic factors, followed by increased ROS production that play crucial roles in dopaminergic cell damage and death [31,32,35,36].”
Shi, B., Raina, J., Lorenzo, A., Busciglio, J., & Gabuzda, D. (1998) · Journal of Neurovirology · doi:10.3109/13550289809114529 · Cited by 192
“…of oxygen free radicals in neural cells, we exposed live primary human brain cultures to the redox-sensitive ¯uorescent dye 2,7 dichloro¯uorescein diacetate (DCFDA) (10 mM) for 1 h at 378C as described (Busciglio and Yankner, 1995) following treatment with Tat or TNF-a alone or in combination.”
BackgroundMethodInfluentialSelf-citationEndoplasmic Reticulum Stress Proteins Block Oxidant-induced Ca2+ Increases and Cell Death
Liu, H., Miller, E., van de Water, B., & Stevens, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12858 · Cited by 190
Fullerton, H. J., Ditelberg, J. S., Chen, S. F., Sarco, D. P., Chan, P. H., Epstein, C. J., & Ferriero, D. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440311 · Cited by 183
Biomarkers of oxidative stress are significantly elevated in Down syndrome
Jovanovic, S. V., Clements, D., & MacLeod, K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00137-3 · Cited by 183
Adaptive Downregulation of Mitochondrial Function in Down Syndrome
Helguera, P., Seiglie, J., Rodriguez, J., Hanna, M., Helguera, G., & Busciglio, J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.005 · Cited by 178
“132 Cell Metabolism 17, 132–140, January 8, 2013 a2013 Elsevier In survival (Busciglio and Yankner, 1995), and both DS neurons and astrocytes display an abnormal pattern of protein processing consistent with chronic energy deficits (Busciglio et al.”
BackgroundInfluentialSelf-citationTakahashi, M., Doré, S., Ferris, C. D., Tomita, T., Sawa, A., Wolosker, H., Borchelt, D. R., Iwatsubo, T., Kim, S.-H., Thinakaran, G., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00125-2 · Cited by 183
Taub, J. W., Huang, X., Matherly, L. H., Stout, M. L., Buck, S. A., Massey, G. V., Becton, D. L., Chang, M. N., Weinstein, H. J., & Ravindranath, Y. (1999) · PubMed · doi:10.1182/blood.v94.4.1393 · Cited by 184
Metadata
- Authors
- Busciglio, J., & Yankner, B. A.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Nature
- Published
- 1995-12
- Volume
- 378
- Issue
- 6559
- Pages
- 776-779
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992689843
- Cited by
- 741
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 30 · 2012: 32
- FWCI
- 57.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Down syndrome, neuronal apoptosis, reactive oxygen species, lipid peroxidation, cortical neurons, neurodegeneration, radical scavengers, catalase, Alzheimer's disease, intellectual disability, oxidative stress
- MeSH terms
- Alzheimer Disease, Antioxidants, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Cycloheximide, Dactinomycin, Down Syndrome, Fluoresceins, Humans, Nerve Degeneration, Neurons, Lipid Peroxidation, Free Radical Scavengers, Apoptosis, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.